Skip to main content
Top
Published in: Indian Journal of Pediatrics 1/2017

01-01-2017 | Clinical Brief

Primary Carnitine Deficiency – A Rare Treatable Cause of Cardiomyopathy and Massive Hepatomegaly

Authors: Shivani Deswal, Sunita Bijarnia-Mahay, Vinamr Manocha, Keiichi Hara, Yosuke Shigematsu, Renu Saxena, Ishwar C. Verma

Published in: Indian Journal of Pediatrics | Issue 1/2017

Login to get access

Abstract

Systemic primary carnitine deficiency (CDSP) is a rare autosomal recessive disorder caused by a defect in plasma membrane uptake of carnitine due to SLC22A5 gene mutations. A nine-mo-old boy presented with hypertrophic cardiomyopathy, massive hepatomegaly and jaundice. Metabolic testing revealed very low free carnitine levels. Genetic analysis using Sanger sequencing method revealed compound heterozygous mutations in SLC22A5 gene, c. 1354 G > A (p. Glu452Lys, previously reported) and c.231_234del (novel frame-shift). Oral carnitine supplementation resulted in improved clinical outcome with ejection fraction to 75 % and normalization of liver size and enzymes after 3 mo.
Appendix
Available only for authorised users
Literature
1.
go back to reference Li FY, El-Hattab AW, Bawle EV, et al. Molecular spectrum of SLC22A5 (OCTN2) gene mutations detected in 143 subjects evaluated for systemic carnitine deficiency. Hum Mutat. 2010;31:E1632–51.CrossRefPubMed Li FY, El-Hattab AW, Bawle EV, et al. Molecular spectrum of SLC22A5 (OCTN2) gene mutations detected in 143 subjects evaluated for systemic carnitine deficiency. Hum Mutat. 2010;31:E1632–51.CrossRefPubMed
2.
go back to reference Chapoy PR, Angelini C, Brown WJ, Stiff JE, Shug AL, Cederbaum SD. Systemic carnitine deficiency--a treatable inherited lipid-storage disease presenting as Reye’s syndrome. N Engl J Med. 1980;303:1389–94.CrossRefPubMed Chapoy PR, Angelini C, Brown WJ, Stiff JE, Shug AL, Cederbaum SD. Systemic carnitine deficiency--a treatable inherited lipid-storage disease presenting as Reye’s syndrome. N Engl J Med. 1980;303:1389–94.CrossRefPubMed
3.
go back to reference Koizumi A, Nozaki J, Ohura T, et al. Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. Hum Mol Genet. 1999;8:2247–54.CrossRefPubMed Koizumi A, Nozaki J, Ohura T, et al. Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. Hum Mol Genet. 1999;8:2247–54.CrossRefPubMed
4.
go back to reference Lund AM, Joensen F, Hougaard DM, et al. Carnitine transporter and holocarboxylase synthetase deficiencies in the Faroe Islands. J Inherit Metab Dis. 2007;30:341–9.CrossRefPubMed Lund AM, Joensen F, Hougaard DM, et al. Carnitine transporter and holocarboxylase synthetase deficiencies in the Faroe Islands. J Inherit Metab Dis. 2007;30:341–9.CrossRefPubMed
5.
go back to reference Rasmussen J, Nielsen OW, Janzen N, et al. Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands. J Inherit Metab Dis. 2014;37:215–22.CrossRefPubMed Rasmussen J, Nielsen OW, Janzen N, et al. Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands. J Inherit Metab Dis. 2014;37:215–22.CrossRefPubMed
6.
go back to reference Flanagan JL, Simmons PA, Vehige J, Willcox MD, Garrett Q. Role of carnitine in disease. Nutr Metab (Lond). 2010;7:30.CrossRef Flanagan JL, Simmons PA, Vehige J, Willcox MD, Garrett Q. Role of carnitine in disease. Nutr Metab (Lond). 2010;7:30.CrossRef
7.
go back to reference Magoulas PL, El-Hattab AW. Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management. Orphanet J Rare Dis. 2012;7:68.CrossRefPubMedPubMedCentral Magoulas PL, El-Hattab AW. Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management. Orphanet J Rare Dis. 2012;7:68.CrossRefPubMedPubMedCentral
8.
go back to reference Mahale RR, Mehta A, Timmappaya A, Srinivasa R. Primary carnitine deficiency as a cause of metabolic leukoencephalopathy: report of one case. Neurol India. 2016;64:166–8.CrossRefPubMed Mahale RR, Mehta A, Timmappaya A, Srinivasa R. Primary carnitine deficiency as a cause of metabolic leukoencephalopathy: report of one case. Neurol India. 2016;64:166–8.CrossRefPubMed
10.
go back to reference Kilic M, Ozgül RK, Coskun T, et al. Identification of mutations and evaluation of cardiomyopathy in Turkish patients with primary carnitine deficiency. JIMD Rep. 2012;3:17–23.CrossRefPubMed Kilic M, Ozgül RK, Coskun T, et al. Identification of mutations and evaluation of cardiomyopathy in Turkish patients with primary carnitine deficiency. JIMD Rep. 2012;3:17–23.CrossRefPubMed
11.
go back to reference Lee NC, Tang NL, Chien YH, et al. Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening. Mol Genet Metab. 2010;100:46–50.CrossRefPubMed Lee NC, Tang NL, Chien YH, et al. Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening. Mol Genet Metab. 2010;100:46–50.CrossRefPubMed
Metadata
Title
Primary Carnitine Deficiency – A Rare Treatable Cause of Cardiomyopathy and Massive Hepatomegaly
Authors
Shivani Deswal
Sunita Bijarnia-Mahay
Vinamr Manocha
Keiichi Hara
Yosuke Shigematsu
Renu Saxena
Ishwar C. Verma
Publication date
01-01-2017
Publisher
Springer India
Published in
Indian Journal of Pediatrics / Issue 1/2017
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-016-2227-7

Other articles of this Issue 1/2017

Indian Journal of Pediatrics 1/2017 Go to the issue